Annual Net Income
$1.40 B
-$119.50 M-7.85%
31 December 2023
Summary:
Edwards Lifesciences annual net profit is currently $1.40 billion, with the most recent change of -$119.50 million (-7.85%) on 31 December 2023. During the last 3 years, it has risen by +$579.00 million (+70.32%). EW annual net income is now -7.85% below its all-time high of $1.52 billion, reached on 31 December 2022.EW Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$3.07 B
+$2.70 B+738.33%
30 September 2024
Summary:
Edwards Lifesciences quarterly net profit is currently $3.07 billion, with the most recent change of +$2.70 billion (+738.33%) on 30 September 2024. Over the past year, it has increased by +$2.69 billion (+697.82%). EW quarterly net income is now at all-time high.EW Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$4.16 B
+$2.69 B+182.34%
30 September 2024
Summary:
Edwards Lifesciences TTM net profit is currently $4.16 billion, with the most recent change of +$2.69 billion (+182.34%) on 30 September 2024. Over the past year, it has increased by +$2.73 billion (+190.65%). EW TTM net income is now at all-time high.EW TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | +697.8% | +190.7% |
| 3 y3 years | +70.3% | +802.9% | +181.5% |
| 5 y5 years | +94.2% | +1017.9% | +437.5% |
EW Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.8% | +70.3% | at high | +899.9% | at high | +199.3% |
| 5 y | 5 years | -7.8% | +94.2% | at high | +2619.1% | at high | +459.3% |
| alltime | all time | -7.8% | +615.6% | at high | +1093.8% | at high | +1524.3% |
Edwards Lifesciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.07 B(+738.3%) | $4.16 B(+182.3%) |
| June 2024 | - | $366.30 M(+4.1%) | $1.47 B(+4.2%) |
| Mar 2024 | - | $351.90 M(-4.9%) | $1.41 B(+0.8%) |
| Dec 2023 | $1.40 B(-7.9%) | $369.90 M(-3.9%) | $1.40 B(-2.0%) |
| Sept 2023 | - | $384.90 M(+25.3%) | $1.43 B(+3.0%) |
| June 2023 | - | $307.10 M(-9.8%) | $1.39 B(-6.7%) |
| Mar 2023 | - | $340.50 M(-14.5%) | $1.49 B(-2.2%) |
| Dec 2022 | $1.52 B(+1.3%) | $398.40 M(+16.0%) | $1.52 B(+4.3%) |
| Sept 2022 | - | $343.50 M(-15.5%) | $1.46 B(+0.2%) |
| June 2022 | - | $406.40 M(+8.8%) | $1.46 B(-5.4%) |
| Mar 2022 | - | $373.60 M(+11.4%) | $1.54 B(+2.4%) |
| Dec 2021 | $1.50 B(+82.5%) | $335.30 M(-1.4%) | $1.50 B(+1.7%) |
| Sept 2021 | - | $340.10 M(-30.5%) | $1.48 B(+1.0%) |
| June 2021 | - | $489.50 M(+44.7%) | $1.46 B(+71.8%) |
| Mar 2021 | - | $338.20 M(+9.3%) | $851.00 M(+3.4%) |
| Dec 2020 | $823.40 M(-21.3%) | $309.50 M(-4.8%) | $823.40 M(+3.7%) |
| Sept 2020 | - | $325.20 M(-366.8%) | $794.10 M(+6.8%) |
| June 2020 | - | -$121.90 M(-139.2%) | $743.60 M(-32.9%) |
| Mar 2020 | - | $310.60 M(+10.8%) | $1.11 B(+5.8%) |
| Dec 2019 | $1.05 B(+45.0%) | $280.20 M(+2.0%) | $1.05 B(+35.3%) |
| Sept 2019 | - | $274.70 M(+13.4%) | $773.70 M(+6.7%) |
| June 2019 | - | $242.30 M(-3.0%) | $724.90 M(-5.3%) |
| Mar 2019 | - | $249.70 M(+3467.1%) | $765.30 M(+6.0%) |
| Dec 2018 | $722.20 M(+23.7%) | $7.00 M(-96.9%) | $722.20 M(+1.4%) |
| Sept 2018 | - | $225.90 M(-20.1%) | $712.40 M(+8.5%) |
| June 2018 | - | $282.70 M(+36.8%) | $656.60 M(+17.3%) |
| Mar 2018 | - | $206.60 M(-7478.6%) | $560.00 M(-4.0%) |
| Dec 2017 | $583.60 M(+2.5%) | -$2.80 M(-101.6%) | $583.60 M(-21.7%) |
| Sept 2017 | - | $170.10 M(-8.6%) | $744.90 M(+4.0%) |
| June 2017 | - | $186.10 M(-19.2%) | $716.20 M(+9.1%) |
| Mar 2017 | - | $230.20 M(+45.2%) | $656.70 M(+15.3%) |
| Dec 2016 | $569.50 M(+15.1%) | $158.50 M(+12.1%) | $569.50 M(+3.2%) |
| Sept 2016 | - | $141.40 M(+11.7%) | $551.70 M(+4.4%) |
| June 2016 | - | $126.60 M(-11.5%) | $528.40 M(+2.7%) |
| Mar 2016 | - | $143.00 M(+1.6%) | $514.50 M(+4.0%) |
| Dec 2015 | $494.90 M(-39.0%) | $140.70 M(+19.1%) | $494.90 M(+6.8%) |
| Sept 2015 | - | $118.10 M(+4.8%) | $463.40 M(+5.3%) |
| June 2015 | - | $112.70 M(-8.7%) | $439.90 M(-49.7%) |
| Mar 2015 | - | $123.40 M(+13.0%) | $874.20 M(+7.8%) |
| Dec 2014 | $811.10 M(+108.5%) | $109.20 M(+15.4%) | $811.10 M(+4.4%) |
| Sept 2014 | - | $94.60 M(-82.7%) | $777.00 M(+2.3%) |
| June 2014 | - | $547.00 M(+807.1%) | $759.20 M(+148.5%) |
| Mar 2014 | - | $60.30 M(-19.7%) | $305.50 M(-21.5%) |
| Dec 2013 | $389.10 M(+33.5%) | $75.10 M(-2.2%) | $389.10 M(-3.5%) |
| Sept 2013 | - | $76.80 M(-17.7%) | $403.40 M(+1.9%) |
| June 2013 | - | $93.30 M(-35.2%) | $395.80 M(+6.9%) |
| Mar 2013 | - | $143.90 M(+61.0%) | $370.30 M(+27.0%) |
| Dec 2012 | $291.50 M | $89.40 M(+29.2%) | $291.50 M(+9.9%) |
| Sept 2012 | - | $69.20 M(+2.1%) | $265.20 M(+7.1%) |
| June 2012 | - | $67.80 M(+4.1%) | $247.60 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $65.10 M(+3.2%) | $237.90 M(+0.5%) |
| Dec 2011 | $236.70 M(+8.6%) | $63.10 M(+22.3%) | $236.70 M(-0.7%) |
| Sept 2011 | - | $51.60 M(-11.2%) | $238.40 M(+1.5%) |
| June 2011 | - | $58.10 M(-9.1%) | $234.80 M(+0.3%) |
| Mar 2011 | - | $63.90 M(-1.4%) | $234.20 M(+7.4%) |
| Dec 2010 | $218.00 M(-4.8%) | $64.80 M(+35.0%) | $218.00 M(+8.6%) |
| Sept 2010 | - | $48.00 M(-16.5%) | $200.80 M(-11.3%) |
| June 2010 | - | $57.50 M(+20.5%) | $226.30 M(+4.6%) |
| Mar 2010 | - | $47.70 M(+0.2%) | $216.30 M(-5.6%) |
| Dec 2009 | $229.10 M(+77.7%) | $47.60 M(-35.2%) | $229.10 M(+4.3%) |
| Sept 2009 | - | $73.50 M(+54.7%) | $219.60 M(+22.7%) |
| June 2009 | - | $47.50 M(-21.5%) | $179.00 M(+4.6%) |
| Mar 2009 | - | $60.50 M(+58.8%) | $171.20 M(+32.8%) |
| Dec 2008 | $128.90 M(+14.1%) | $38.10 M(+15.8%) | $128.90 M(+20.9%) |
| Sept 2008 | - | $32.90 M(-17.1%) | $106.60 M(+3.7%) |
| June 2008 | - | $39.70 M(+118.1%) | $102.80 M(+4.9%) |
| Mar 2008 | - | $18.20 M(+15.2%) | $98.00 M(-13.3%) |
| Dec 2007 | $113.00 M(-13.4%) | $15.80 M(-45.7%) | $113.00 M(-4.2%) |
| Sept 2007 | - | $29.10 M(-16.6%) | $117.90 M(+1.1%) |
| June 2007 | - | $34.90 M(+5.1%) | $116.60 M(-1.0%) |
| Mar 2007 | - | $33.20 M(+60.4%) | $117.80 M(-9.8%) |
| Dec 2006 | $130.50 M(+65.2%) | $20.70 M(-25.5%) | $130.60 M(-11.9%) |
| Sept 2006 | - | $27.80 M(-23.0%) | $148.20 M(+27.8%) |
| June 2006 | - | $36.10 M(-21.5%) | $116.00 M(+23.7%) |
| Mar 2006 | - | $46.00 M(+20.1%) | $93.80 M(+18.7%) |
| Dec 2005 | $79.00 M(+4547.1%) | $38.30 M(-970.5%) | $79.00 M(+18.6%) |
| Sept 2005 | - | -$4.40 M(-131.7%) | $66.60 M(-20.1%) |
| June 2005 | - | $13.90 M(-55.4%) | $83.40 M(-12.2%) |
| Mar 2005 | - | $31.20 M(+20.5%) | $95.00 M(+5488.2%) |
| Dec 2004 | $1.70 M(-97.8%) | $25.90 M(+108.9%) | $1.70 M(-132.1%) |
| Sept 2004 | - | $12.40 M(-51.4%) | -$5.30 M(-177.9%) |
| June 2004 | - | $25.50 M(-141.1%) | $6.80 M(+183.3%) |
| Mar 2004 | - | -$62.10 M(-428.6%) | $2.40 M(-97.0%) |
| Dec 2003 | $79.00 M(+41.8%) | $18.90 M(-22.9%) | $79.00 M(-3.4%) |
| Sept 2003 | - | $24.50 M(+16.1%) | $81.80 M(+105.0%) |
| June 2003 | - | $21.10 M(+45.5%) | $39.90 M(-19.2%) |
| Mar 2003 | - | $14.50 M(-33.2%) | $49.40 M(-11.3%) |
| Dec 2002 | $55.70 M(-588.6%) | $21.70 M(-224.7%) | $55.70 M(+9.0%) |
| Sept 2002 | - | -$17.40 M(-156.9%) | $51.10 M(-38.4%) |
| June 2002 | - | $30.60 M(+47.1%) | $83.00 M(-2615.2%) |
| Mar 2002 | - | $20.80 M(+21.6%) | -$3.30 M(-71.1%) |
| Dec 2001 | -$11.40 M(-95.8%) | $17.10 M(+17.9%) | -$11.40 M(+208.1%) |
| Sept 2001 | - | $14.50 M(-126.0%) | -$3.70 M(-73.2%) |
| June 2001 | - | -$55.70 M(-538.6%) | -$13.80 M(-94.8%) |
| Mar 2001 | - | $12.70 M(-48.8%) | -$267.10 M(+1.6%) |
| Dec 2000 | -$272.00 M(-431.7%) | $24.80 M(+463.6%) | -$262.80 M(-8.6%) |
| Sept 2000 | - | $4.40 M(-101.4%) | -$287.60 M(-1.5%) |
| June 2000 | - | -$309.00 M(-1917.6%) | -$292.00 M(-1817.6%) |
| Mar 2000 | - | $17.00 M | $17.00 M |
| Dec 1999 | $82.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual net profit?
- What is the all time high annual net income for Edwards Lifesciences?
- What is Edwards Lifesciences annual net income year-on-year change?
- What is Edwards Lifesciences quarterly net profit?
- What is the all time high quarterly net income for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly net income year-on-year change?
- What is Edwards Lifesciences TTM net profit?
- What is the all time high TTM net income for Edwards Lifesciences?
- What is Edwards Lifesciences TTM net income year-on-year change?
What is Edwards Lifesciences annual net profit?
The current annual net income of EW is $1.40 B
What is the all time high annual net income for Edwards Lifesciences?
Edwards Lifesciences all-time high annual net profit is $1.52 B
What is Edwards Lifesciences annual net income year-on-year change?
Over the past year, EW annual net profit has changed by -$119.50 M (-7.85%)
What is Edwards Lifesciences quarterly net profit?
The current quarterly net income of EW is $3.07 B
What is the all time high quarterly net income for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly net profit is $3.07 B
What is Edwards Lifesciences quarterly net income year-on-year change?
Over the past year, EW quarterly net profit has changed by +$2.69 B (+697.82%)
What is Edwards Lifesciences TTM net profit?
The current TTM net income of EW is $4.16 B
What is the all time high TTM net income for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM net profit is $4.16 B
What is Edwards Lifesciences TTM net income year-on-year change?
Over the past year, EW TTM net profit has changed by +$2.73 B (+190.65%)